Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells

European Journal of Immunology

Volumn 35, Issue 5, 2005, Pages 1548-1556

  Lenz, Petra ^a   Lowy, Douglas R ^a   Schiller, John T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dendritic cells; Human; Vaccination; Viral infections

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NUCLEIC ACID; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; BONE MARROW CELL; CELL MATURATION; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA BINDING; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; INNATE IMMUNITY; INTERNALIZATION; LYMPHOCYTE ACTIVATION; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; VACCINATION; VIRUS CAPSID; VIRUS ISOLATION; VIRUS PARTICLE; WART VIRUS;

ANIMALS; CAPSID PROTEINS; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; PAPILLOMAVIRIDAE; T-LYMPHOCYTES; VIRION;

EID: 18844370878     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425547     Document Type: Article

References (44)

1. Liu, Y. J., Kanzler, H., Soumelis, V. and Gilliet, M., Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2001. 2: 585-589.
2. Cella, M., Facchetti, F., Lanzavecchia, A. and Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000. 1: 305-310.
3. + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003. 101: 3520-3526.
4. Dalod, M., Hamilton, T., Salomon, R., Salazar-Mather, T. P., Henry, S. C., Hamilton, J. D. and Biron, C. A., Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003. 197: 885-898.
5. Lund, J., Sato, A., Akira, S., Medzhitov, R. and Iwasaki, A., Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med 2003. 198: 513-520.
6. Yonezawa, A., Morita, R., Takaori-Kondo, A., Kadowaki, N., Kitawaki, T., Hori, T. and Uchiyama, T., Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J. Virol 2003. 77: 3777-3784.
7. Hartmann, G., Weiner, G. J. and Krieg, A. M., CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 1999. 96: 9305-9310.
8. + dendritic cells. J. Immunol 2001. 166: 5000-5007.
9. Belardelli, F. and Gresser, I., The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol. Today 1996. 17: 369-372.
10. Rogge, L., D'Ambrosio, D., Biffi, M., Penna, G., Minetti, L. J., Presky, D. H., Adorini, L. and Sinigaglia, F., The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol 1998. 161: 6567-6574.
11. Jego, G., Palucka, A. K., Blanck, J. P., Chalouni, C., Pascual, V. and Banchereau, J., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003. 19: 225-234.
12. Gilliet, M. and Liu, Y. J., Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum. Immunol 2002. 63: 1149-1155.
13. Gilliet, M. and Liu, Y. J., Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med 2002. 195: 695-704.
14. Gibson, S. J., Lindh, J. M., Riter, T. R,, Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L., Gorden, K. B., Qiu, X., McKane, S. W. et al., Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell. Immunol 2002. 218: 74-86.
15. Schiller, J. T., Papillomavirus-like particle vaccines for cervical cancer. Mol. Med. Today 1999. 5: 209-215.
16. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R. and Schiller, J. T., Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 1992. 89: 12180-12184.
17. Harro, C. D., Pang, Y. Y., Roden, R. B., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A. et al., Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 2001. 93: 284-292.
18. Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M. and Jansen, K. U., A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med 2002. 347: 1645-1651.
19. Lenz, P., Day, P. M., Pang, Y. Y., Frye, S. A., Jensen, P. N., Lowy, D. R. and Schiller, J. T., Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 2001. 166: 5346-5355.
20. Rudolf, M. P., Fausch, S. C., Da Silva, D. M. and Kast, W. M., Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J. Immunol. 2001. 166: 5917-5924.
21. Lenz, P., Thompson, C. D., Day, P. M., Bacot, S. M., Lowy, D. R. and Schiller, J. T., Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells. Clin. Immunol 2003. 106: 231-237.
22. Fausch, S. C., Da Silva, D. M., Rudolf, M. P. and Kast, W. M., Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J. Immunol. 2002. 169: 3242-3249.
23. Da Silva, D. M., Velders, M. P., Nieland, J. D., Schiller, J. T., Nickoloff, B. J. and Kast, W. M., Physical interaction of human papillomavirus virus-like particles with immune cells. Int. Immunol. 2001. 13: 633-641.
24. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F. and Liu, Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med 2001. 194: 863-869.
25. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol 2002. 20: 709-760.
26. Hartmann, G. and Krieg, A. M., Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 2000. 164: 944-953.
27. Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L. and Van Nest, G., Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 2003. 73: 781-792.
28. Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M. and Hartmann, G., Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001. 31: 3026-3037.
29. Emeny, R. T., Wheeler, C. M., Jansen, K. U., Hunt, W. C., Fu, T. M., Smith, J. F., MacMullen, S., Esser, M. T. and Paliard, X., Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J. Virol. 2002. 76: 7832-7842.
30. Pinto, L. A., Edwards, J., Castle, P. E., Harro, C. D., Lowy, D. R., Schiller, J. T., Wallace, D., Kopp, W., Adelsberger, J. W., Baseler, M. W. et al., Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J. Infect. Dis. 2003. 188: 327-338.
31. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
32. Kadowaki, N. and Liu, Y. J., Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol 2002. 63: 1126-1132.
33. Soumelis, V., Scott, I., Liu, Y. J. and Levy, J., Natural type 1 interferon producing cells in HIV infection. Hum. Immunol 2002. 63: 1206-1212.
34. Cirelli, R. and Tyring, S. K., Interferons in human papillomavirus infections. Antiviral. Res. 1994. 24: 191-204.
35. Yliskoski, M., Syrjanen, K., Syrjanen, S., Saarikoskis, S. and Nethersell, A., Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial. Gynecol. Oncol. 1991. 43: 55-60.
36. Sauder, D. N., Immunomodulatory and pharmacologic properties of imiquimod. J. Am. Acad. Dermatol. 2000. 43: S6-11.
37. Turek, L. P., Byrne, J. C., Lowy, D. R., Dvoretzky, I., Friedman, R. M. and Howley, P. M., Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc. Natl. Acad. Sci. USA 1982. 79: 7914-7918.
38. Brouty-Boye, D., Maunoury, M. T. and Lowy, D. R., Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells. Anticancer Res 1988. 8: 197-203.
39. Rothenfusser, S., Tuma, E., Endres, S. and Hartmann, G., Plasmacytoid dendritic cells: the key to CpG(1). Hum. Immunol. 2002. 63: 1111-1119.
40. Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B. and Klinman, D. M., CpG oligodeoxynucleotides as vaccine adjuvants in primates. J. Immunol. 2002. 168: 1659-1663.
41. Kuwana, M., Kaburaki, J., Wright, T. M., Kawakami, Y. and Ikeda, Y., Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur. J. Immunol. 2001. 31: 2547-2557.
42. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med 2001. 193: 1285-1294.
43. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D. R. and Schiller, J. T., Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 1993. 67: 6929-6936.
44. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W. and Schmitz, J., BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000. 165: 6037-6046.